BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18063698)

  • 1. Intravascular inactivation of CCR5 by n-Nonanoyl-CC chemokine ligand 14 and inhibition of allergic airway inflammation.
    Gupta S; Fuchs B; Schulz-Maronde S; Heitland A; Escher SE; Mack M; Tillmann HC; Braun A; Forssmann WG; Elsner J; Forssmann U
    J Leukoc Biol; 2008 Mar; 83(3):765-73. PubMed ID: 18063698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2.
    Gupta S; Erdmann G; Schulz-Maronde S; Escher SE; Richter R; Forssmann WG; Elsner J; Forssmann U
    Allergy; 2008 Oct; 63(10):1317-23. PubMed ID: 18782110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR1- and CCR5-mediated inactivation of leukocytes by a nonglycosaminoglycan (non-GAG)-binding variant of n-nonanoyl-CCL14 (NNY-CCL14).
    Gupta S; Rieder S; Richter R; Schulz-Maronde S; Manns J; Escher SE; Heitland A; Mack M; Forssmann WG; Elsner J; Forssmann U
    J Leukoc Biol; 2010 Aug; 88(2):383-92. PubMed ID: 20483925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
    Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
    Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation.
    Forssmann U; Hartung I; Bälder R; Fuchs B; Escher SE; Spodsberg N; Dulkys Y; Walden M; Heitland A; Braun A; Forssmann WG; Elsner J
    J Immunol; 2004 Sep; 173(5):3456-66. PubMed ID: 15322211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional characterization of CC chemokine CCL14.
    Blain KY; Kwiatkowski W; Zhao Q; La Fleur D; Naik C; Chun TW; Tsareva T; Kanakaraj P; Laird MW; Shah R; George L; Sanyal I; Moore PA; Demeler B; Choe S
    Biochemistry; 2007 Sep; 46(35):10008-15. PubMed ID: 17691823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1.
    Gupta S; Schulz-Maronde S; Kutzleb C; Richter R; Forssmann WG; Kapp A; Forssmann U; Elsner J
    J Leukoc Biol; 2005 Nov; 78(5):1175-84. PubMed ID: 16204626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3.
    Elsner J; Dulkys Y; Gupta S; Escher SE; Forssmann WG; Kapp A; Forssmann U
    Allergy; 2005 Nov; 60(11):1386-93. PubMed ID: 16197470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.
    Chvatchko Y; Proudfoot AE; Buser R; Juillard P; Alouani S; Kosco-Vilbois M; Coyle AJ; Nibbs RJ; Graham G; Offord RE; Wells TN
    J Immunol; 2003 Nov; 171(10):5498-506. PubMed ID: 14607956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.
    Richter R; Casarosa P; Ständker L; Münch J; Springael JY; Nijmeijer S; Forssmann WG; Vischer HF; Vakili J; Detheux M; Parmentier M; Leurs R; Smit MJ
    J Immunol; 2009 Jul; 183(2):1229-37. PubMed ID: 19553544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of eotaxin-3 (CCL26) in alveolar type II epithelial cells.
    Abonyo BO; Lebby KD; Tonry JH; Ahmad M; Heiman AS
    Cytokine; 2006 Dec; 36(5-6):237-44. PubMed ID: 17350279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of chemokine activity by posttranslational modification.
    Mortier A; Van Damme J; Proost P
    Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease.
    Hogaboam CM; Carpenter KJ; Schuh JM; Proudfoot AA; Bridger G; Buckland KF
    Pharmacol Ther; 2005 Sep; 107(3):314-28. PubMed ID: 16009428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma.
    Méndez-Enríquez E; Medina-Tamayo J; Soldevila G; Fortoul TI; Anton B; Flores-Romo L; García-Zepeda EA
    Int Immunopharmacol; 2014 May; 20(1):1-11. PubMed ID: 24560857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1alpha.
    Gaga M; Ong YE; Benyahia F; Aizen M; Barkans J; Kay AB
    Allergy; 2008 Jun; 63(6):703-11. PubMed ID: 18070228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4(+) T cells and spontaneous abortion in mice.
    Jiang PJ; Lin QD; Bao SM; Zhao AM; Zhang Y; Xiao SJ
    Chin Med J (Engl); 2009 Feb; 122(4):390-5. PubMed ID: 19302742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice.
    Schuh JM; Blease K; Hogaboam CM
    FASEB J; 2002 Feb; 16(2):228-30. PubMed ID: 11744622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
    Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
    Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.